2 бет - Ең жақсы Галлий 68 (ПСМА) көмегімен ПЭТ-КТ дәрігерлері - ЖОҒ-66 дәрігерлер

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Antonio Cubillo Gracián is a specialist in Medical Oncology. He has broad teaching and clinical experience at USP CEU and HM CIOCC. He has directed postgraduate research as Director of the Master’s in Clinical and Applied Research in Oncology. Since 2009, he has tutored more than 100 students, residents, and rotating staff.

Dr. Cubillo has advanced oncology education by teaching subjects such as General Medical Pathology, Oncology, Bioethics, and Pathophysiology. He has organized international courses on digestive neoplasms. He has also worked with leading institutions, including MD Anderson Cancer Center. His academic leadership and clinical mentorship have set high standards in oncology training and research.

Dr. Kayihan Engin is a Radiation Oncologist. He earned his medical degree from Uludağ University Medical College in 1983. He completed his residency in Radiation Oncology at the Center of Oncology & Nuclear Medicine in Istanbul in 1990. From 1990 to 1994, he pursued a post-doctoral fellowship in Thermoradiotherapy at Thomas Jefferson University in the USA.

Dr. Engin has held key academic and leadership roles. He served as Professor, Chairman, and Faculty Accreditation Coordinator at Uludağ University Medical College from 1991 to 2005. He was also Professor and Director at Anadolu Medical Center between 2004 and 2017. Since 2017, he has led the Oncological Sciences departments at Ceylan International and Medicana Bursa Hospitals. Dr. Engin is known for his work in improving cancer treatment and medical education standards in Turkey.

Dr. Chaitainya Borde is a nuclear medicine specialist with 12 years of clinical experience. He is skilled in advanced nuclear scans, PET-CT imaging, and nuclear cardiology. He works in both diagnostic and therapeutic nuclear medicine.

Dr. Borde has performed over 30,000 PET scans. He has managed more than 1,000 thyroid cancer patients. He is experienced in radioiodine and Lu-177 RN therapies. He has also published research papers in respected medical journals, showing his dedication to academic work.

Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.

Dr. Ahmer Arif Shaikh, MDS (Oral & Maxillofacial Surgery), is a specialist in Surgical Oncology. He has 3 years of experience at HCG Manavata Cancer Centre, Nashik. He focuses on oral cancer treatment, organ preservation, and functional rehabilitation for oral cancer patients.

Dr. Shaikh has completed a Fellowship in Head & Neck Surgical Oncology. He is skilled in complex maxillofacial and head & neck surgeries. He is also an active researcher with several publications in reputed journals. His work shows a strong commitment to improving cancer care.

Dr. Lalit Banswal is an experienced oncological surgeon with 10 years in the field. He has performed more than 10,000 major surgeries. He earned his MBBS from MIMER, Pune, and completed his MS at GMC Panaji. He also completed a fellowship in Surgical Oncology at Tata Medical Centre, Kolkata, with a focus on gastrointestinal cancers.

Dr. Banswal has worked as a Co-principal Investigator in several research projects. He has published his work in both national and international journals. He is known for his patient-friendly and ethical approach. His main expertise is in Minimal Invasive Cancer Surgeries, where he consistently delivers excellent results.

Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.

He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.

Dr. Sridhar P.S. is a skilled radiation oncologist. He earned his Bachelor of Medicine from Mysore University. He completed his MD in Radiotherapy at Banaras Hindu University. He also holds a Diplomate of the National Board in Radiotherapy. This shows his advanced training and dedication to quality care.

Dr. Sridhar is a member of several professional groups. These include the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology. He is known for his effective cancer treatments and focus on new therapies. His work has made a positive impact in the field of oncology.

Education

Ankara Training and Research Hospital, Urology Residency, 1992-1997, Ankara/Turkey

Uludağ University Faculty of Medicine, Doctor of Medicine Education, 1982-1988, Bursa/Turkey

Experience

Taksim Training and Research Hospital, 2009-2016, Istanbul/Turkey

Bağcılar Training and Research Hospital, 2007-2009, Istanbul/Turkey

Ankara Training and Research Hospital, 2000-2007, Ankara/Turkey

Bergama State Hospital, 1997-2000, Izmir/Turkey

Ankara Training and Research Hospital, 1992-1997, Ankara/Turkey

Scientific Memberships

• Turkish Urology Association
•  
• European Association of Urology
•  
• Turkish Urological Association North Marmara
•  
• American Urological Association

2001 жылы доктор Серткая Кония Мерам Ғылым орта мектебін бітіріп, сол жылы Гази университетінің медицина факультетіне түсіп, 2008 жылы бітірді. 2014 жылы Хайдарпаша Нумуна оқу және зерттеу ауруханасында урология мамандығын аяқтап, урология маманы атанды.

Маман болғаннан бері ол Андрологияның қосымша саласына назар аударып, әртүрлі оқыту сессиялары мен конференцияларға қатысып, әлемнің жетекші Андрология профессорларымен бірге операциялар жасаған. 2017 жылы Еуропа Урология қауымдастығының жүргізген жазбаша және ауызша емтихандарынан өтіп, "FEBU" атағын алды.

2020 жылы доктор Серткая Урология доценті атағына ие болды. 2008 жылы басталған Урология және Андрологиядағы сапары 2022 жылы негізін қалаған Andro Expertise Ерлер денсаулығы және эстетика орталығында жалғасуда. Ол өз клиникасында пациенттерді қабылдап, серіктес ауруханаларда операциялар жүргізеді.

Доктор Виола Фокс BKZ Золингендегі Гематология, Онкология және Паллиативтік медицина клиникасының бас дәрігері болып табылады. Бұл клиника сертификатталған пәнаралық қатерлі ісік орталығы. Доктор Фокс ісік ауруларын дәрі-дәрмекпен емдеуде Германия мен Еуропадағы жетекші сарапшы болып табылады. Ол осы салада 15 жылдан астам тәжірибесі бар.

Ол Германияның Онкология және Гематология-онкология Қоғамының (GDHO), Германия Дәрігерлер қауымдастығының және Американдық Қатерлі Ісік Зерттеу Қауымдастығының мүшесі болып табылады. Доктор Фокс молекулалық биология бойынша да зерттеулер жүргізеді. Оның жұмысы қатерлі ісікті емдеу мен молекулалық диагностика саласының алға жылжыуына қолдау көрсетеді.

Оның негізгі маманданған салалары химиотерапия, иммунотерапия, мақсатты терапия және радиациялық терапия болып табылады. Доктор Фокс инновациялық әдістері мен пациенттерге қамқорлық жасаудағы жоғары құлшынысымен танымал. Оның күш-жігері жоғары қалпына келу көрсеткіштерімен және әріптестерінің мойындауымен ерекшеленеді.